Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT06973005
Status:
COMPLETED
Last Update Posted:
2025-07-24
First Post:
2025-05-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2025-05-07
First Submit QC Date:
None
Study First Post Date:
2025-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-23
Last Update Post Date:
2025-07-24
Last Update Post Date Type:
ACTUAL